The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Ralf Morgenstern sits on this spectrum.
This scientist: 187 publications — 44th percentile
44% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 1,028 publications or more.
The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Ralf Morgenstern sits on this spectrum.
This scientist: 59 D-Index — 38th percentile
38% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 167 D-Index or more.
Ralf Morgenstern is primarily affiliated with the Karolinska Institute in Sweden and has contributed significantly to the field of Biochemistry, Genetics, and Molecular Biology. Their research encompasses a range of topics with a focus on molecular mechanisms related to cancer, enzyme function, and cellular stress responses.
The main topics of Ralf Morgenstern's work include:
These topics relate closely to their primary subfields of study, which include:
Ralf Morgenstern has published extensively, with key papers appearing in various respected venues. Some notable recent publications are:
Their frequent coauthors include:
Ralf Morgenstern's work spans various publication venues with notable appearances in:
Their research has focused on biochemical pathways involving glutathione transferases, particularly microsomal glutathione transferase 1 (MGST1), and its roles in cancer progression, metastasis, and enzyme regulation. Studies investigating the enzyme's function in ferroptosis and oxidative stress mechanisms highlight a combination of biochemical, genetic, and pharmacological approaches.
By examining prostaglandin synthesis and its modulation, they have also contributed to understanding inflammatory mediators and their roles in disease contexts, touching upon the pharmacological implications of nonsteroidal anti-inflammatory drugs (NSAIDs).
This body of work positions Ralf Morgenstern within a multidisciplinary framework bridging molecular biology, genetics, and pharmacology, addressing complex biological systems relevant to health and disease.
Hiroyuki Kobori;Masaomi Nangaku;L. Gabriel Navar;Akira Nishiyama
Per-Johan Jakobsson;Staffan Thorén;Ralf Morgenstern;Bengt Samuelsson
B Mannervik;Y C Awasthi;P G Board;J D Hayes
Bengt Samuelsson;Ralf Morgenstern;Per-Johan Jakobsson
Per-Johan Jakobsson;Ralf Morgenstern;Joseph Mancini;Anthony Ford-Hutchinson
Lena Forsberg;Ulf de Faire;Ralf Morgenstern
Lena Forsberg;Louise Lyrenäs;Ralf Morgenstern;Ulf de Faire
Ralf Morgenstern;Claes Guthenberg;Joseph W. Depierre
Per-Johan Jakobsson;Ralf Morgenstern;Joseph Mancini;Anthony Ford-Hutchinson
Staffan Thorén;Rolf Weinander;Sipra Saha;Caroline Jegerschöld
Ralf Morgenstern;Gerd Lundqvist;Göran Andersson;Lennart Balk
Caroline Jegerschöld;Sven-Christian Pawelzik;Pasi Purhonen;Priyaranjan Bhakat
Rosanna Rinaldi;Erik Eliasson;Stellan Swedmark;Ralf Morgenstern
Erik Melen;Fredrik Nyberg;Cecilia M. Lindgren;Niklas Berglind
R Morgenstern;J W DePierre;H Jörnvall
Anders Bresell;Rolf Weinander;Gerd Lundqvist;Haider Raza
Peter J. Holm;Priyaranjan Bhakat;Caroline Jegerschöld;Nobuhiko Gyobu
Erifili Mosialou;Gunilla Ekström;Anton E.P. Adang;Ralf Morgenstern
Lena Forsberg;Lisa Leeb;Staffan Thorén;Ralf Morgenstern
Xianghui Zeng;Ralf Morgenstern;Andreas M. Nyström
If you think any of the details on this page are incorrect, let us know.
Aarhus University
Royal Holloway University of London
Taipei Veterans General Hospital
Aix-Marseille University
Yonsei University
Environment and Climate Change Canada
Hokkaido University
National Center for Atmospheric Research
Bangor University
Novartis (Switzerland)
The Ohio State University
Pacific Northwest National Laboratory
Razi University
University of Messina
Southern Methodist University
University of Strathclyde
